These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 8394093)
21. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. Matsuyama S; Iwadate M; Kondo M; Saitoh M; Hanyu A; Shimizu K; Aburatani H; Mishima HK; Imamura T; Miyazono K; Miyazawa K Cancer Res; 2003 Nov; 63(22):7791-8. PubMed ID: 14633705 [TBL] [Abstract][Full Text] [Related]
22. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma. Ripley D; Tang XM; Ma C; Chegini N Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966 [TBL] [Abstract][Full Text] [Related]
23. Changes in EGF and TGE-beta receptor expression reflects differentiation of rat malignant oral keratinocytes. Game S; Stone A; Scully C; Prime S Biochem Soc Trans; 1991 Apr; 19(2):189S. PubMed ID: 1653725 [No Abstract] [Full Text] [Related]
24. [Structure and function of transforming growth factor-beta]. Miyazono K Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1350-6. PubMed ID: 1651541 [No Abstract] [Full Text] [Related]
25. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma. Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633 [TBL] [Abstract][Full Text] [Related]
26. Transforming growth factors-beta as regulators of cellular growth and phenotype. Laiho M; Keski-Oja J Crit Rev Oncog; 1992; 3(1-2):1-26. PubMed ID: 1312867 [TBL] [Abstract][Full Text] [Related]
27. Resistance to growth inhibition by transforming growth factor-beta in malignant glioma cells with functional receptors. Isoe S; Naganuma H; Nakano S; Sasaki A; Satoh E; Nagasaka M; Maeda S; Nukui H J Neurosurg; 1998 Mar; 88(3):529-34. PubMed ID: 9488308 [TBL] [Abstract][Full Text] [Related]
28. Transforming growth factor-beta: a general review. Lawrence DA Eur Cytokine Netw; 1996 Sep; 7(3):363-74. PubMed ID: 8954178 [TBL] [Abstract][Full Text] [Related]
29. Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells. Bartlett JM; Rabiasz GJ; Scott WN; Langdon SP; Smyth JF; Miller WR Br J Cancer; 1992 May; 65(5):655-60. PubMed ID: 1586592 [TBL] [Abstract][Full Text] [Related]
30. [TGF-beta and its receptors]. Yuasa Y Gan To Kagaku Ryoho; 1997 Sep; 24(11):1460-4. PubMed ID: 9309142 [TBL] [Abstract][Full Text] [Related]
31. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation. Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms in TGF-beta action. Massagué J; Heino J; Laiho M Ciba Found Symp; 1991; 157():51-9; discussion 59-65. PubMed ID: 1649037 [TBL] [Abstract][Full Text] [Related]
33. Acquisition of TGF-beta 1 resistance: an important progression factor in human renal cell carcinoma. Ramp U; Jaquet K; Reinecke P; Nitsch T; Gabbert HE; Gerharz CD Lab Invest; 1997 May; 76(5):739-49. PubMed ID: 9166292 [TBL] [Abstract][Full Text] [Related]
34. Bifunctional effects of transforming growth factor-beta (TGF-beta) on endothelial cell growth correlate with phenotypes of TGF-beta binding sites. Myoken Y; Kan M; Sato GH; McKeehan WL; Sato JD Exp Cell Res; 1990 Dec; 191(2):299-304. PubMed ID: 1701723 [TBL] [Abstract][Full Text] [Related]
35. Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA. Inagaki M; Moustakas A; Lin HY; Lodish HF; Carr BI Proc Natl Acad Sci U S A; 1993 Jun; 90(11):5359-63. PubMed ID: 8389483 [TBL] [Abstract][Full Text] [Related]
36. Transforming growth factor-beta regulates basal expression of the hsp70 gene family in cultured chicken embryo cells. Takenaka IM; Sadis S; Hightower LE Results Probl Cell Differ; 1991; 17():188-209. PubMed ID: 1803420 [No Abstract] [Full Text] [Related]
37. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate. Sing GK; Ruscetti FW; Beckwith M; Keller JR; Ellingsworth L; Urba WJ; Longo DL Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139 [TBL] [Abstract][Full Text] [Related]
38. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta. Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634 [TBL] [Abstract][Full Text] [Related]
39. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells. Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759 [TBL] [Abstract][Full Text] [Related]
40. TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Barrack ER Prostate; 1997 Apr; 31(1):61-70. PubMed ID: 9108888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]